Literature DB >> 25754500

Incidence of malignant mesothelioma of the pleura in Québec and Canada from 1984 to 2007, and projections from 2008 to 2032.

Alfreda Krupoves1, Michel Camus, Louise De Guire.   

Abstract

BACKGROUND: Continuous increase in male incidence of malignant mesothelioma of the pleura (MMP) despite the drop of asbestos production since 1980 in Québec motivated this study aiming to assess when the rates of MMP will decline.
METHODS: Age-standardized rates and trends were estimated over the 1984-2007 period by sex for Québec versus "Canada-excluding-Québec" (Can-Qc). An age-cohort regression was used to make projections for 2008-2032.
RESULTS: Average rates of MMP in Québec men and women were significantly higher than in Can-Qc. Projected rates peak between 2003 and 2012 in all four study populations and decline thereafter.
CONCLUSION: The higher MMP rates and observed/projected time patterns in Québec men are consistent with past asbestos production and occupational exposures. The excess in Québec women may also be explained by domestic and, for some, by neighborhood exposures. To pursue the decrease in MMP rates beyond 2032, efforts to reduce asbestos exposure should be maintained.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  age-cohort analysis; asbestos; mesothelioma; projections; time trends

Mesh:

Substances:

Year:  2015        PMID: 25754500     DOI: 10.1002/ajim.22442

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  9 in total

1.  Asbestos in Canada: time to change our legacy.

Authors:  Trevor Dummer; Carolyn Gotay
Journal:  CMAJ       Date:  2015-05-04       Impact factor: 8.262

2.  Disease mapping of zero-excessive mesothelioma data in Flanders.

Authors:  Thomas Neyens; Andrew B Lawson; Russell S Kirby; Valerie Nuyts; Kevin Watjou; Mehreteab Aregay; Rachel Carroll; Tim S Nawrot; Christel Faes
Journal:  Ann Epidemiol       Date:  2016-11-01       Impact factor: 3.797

Review 3.  Recent Scientific Evidence Regarding Asbestos Use and Health Consequences of Asbestos Exposure.

Authors:  Manuela Valenzuela; Margarita Giraldo; Sonia Gallo-Murcia; Juliana Pineda; Laura Santos; Juan Pablo Ramos-Bonilla
Journal:  Curr Environ Health Rep       Date:  2016-12

4.  Estimated future incidence of malignant mesothelioma in South Korea: Projection from 2014 to 2033.

Authors:  Kyeong Min Kwak; Domyung Paek; Seung-Sik Hwang; Young-Su Ju
Journal:  PLoS One       Date:  2017-08-17       Impact factor: 3.240

5.  Breath Analysis for Early Detection of Malignant Pleural Mesothelioma: Volatile Organic Compounds (VOCs) Determination and Possible Biochemical Pathways.

Authors:  Alessia Di Gilio; Annamaria Catino; Angela Lombardi; Jolanda Palmisani; Laura Facchini; Teresa Mongelli; Niccolò Varesano; Roberto Bellotti; Domenico Galetta; Gianluigi de Gennaro; Sabina Tangaro
Journal:  Cancers (Basel)       Date:  2020-05-16       Impact factor: 6.639

6.  Global and regional burden of cancer in 2016 arising from occupational exposure to selected carcinogens: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Occup Environ Med       Date:  2020-03       Impact factor: 4.402

7.  Time to Break the "Lock-In" Impediments to Chemicals Management.

Authors:  Jonathan Blumenthal; Miriam L Diamond; Matthew Hoffmann; Zhanyun Wang
Journal:  Environ Sci Technol       Date:  2022-03-19       Impact factor: 9.028

8.  Incidence of mesothelioma in Lombardy, Italy: exposure to asbestos, time patterns and future projections.

Authors:  Carolina Mensi; Sara De Matteis; Barbara Dallari; Luciano Riboldi; Pier Alberto Bertazzi; Dario Consonni
Journal:  Occup Environ Med       Date:  2016-06-16       Impact factor: 4.402

9.  Predictions of Mortality from Pleural Mesothelioma in Italy After the Ban of Asbestos Use.

Authors:  Enrico Oddone; Jordy Bollon; Consuelo Rubina Nava; Marcella Bugani; Dario Consonni; Alessandro Marinaccio; Corrado Magnani; Francesco Barone-Adesi
Journal:  Int J Environ Res Public Health       Date:  2020-01-17       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.